Geron Market Cap

Geron has a market cap or net worth of $1.55 billion as of February 21, 2025. Its market cap has increased by 57.18% in one year.

Market Cap

1.55B

Enterprise Value

1.26B

1-Year Change

57.18%

Ranking

#2137

Market Cap Chart

Since December 1, 1998, Geron's market cap has increased from $159.40M to $1.55B, an increase of 874.63%. That is a compound annual growth rate of 9.06%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	1.59B	-25.71%
Dec 31, 2024	2.14B	86.74%
Dec 29, 2023	1.15B	24.20%
Dec 30, 2022	922.60M	134.88%
Dec 31, 2021	392.80M	-20.44%
Dec 31, 2020	493.70M	81.71%
Dec 31, 2019	271.70M	45.84%
Dec 31, 2018	186.30M	-35.00%
Dec 29, 2017	286.60M	-12.99%
Dec 30, 2016	329.40M	-56.99%
Dec 31, 2015	765.80M	49.89%
Dec 31, 2014	510.90M	-16.42%
Dec 31, 2013	611.30M	231.51%
Dec 31, 2012	184.40M	-5.24%
Dec 30, 2011	194.60M	-63.43%
Dec 31, 2010	532.20M	4.66%
Dec 31, 2009	508.50M	37.54%
Dec 31, 2008	369.70M	-13.62%
Dec 31, 2007	428.00M	-26.52%
Dec 29, 2006	582.50M	4.37%
Dec 30, 2005	558.10M	53.45%
Dec 31, 2004	363.70M	-6.72%
Dec 31, 2003	389.90M	337.60%
Dec 31, 2002	89.10M	-53.52%
Dec 31, 2001	191.70M	-42.86%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	785.00B
UnitedHealth Group	428.62B
Novo Nordisk	391.83B
Johnson & Johnson	390.92B
AbbVie	356.85B
Abbott Laboratories	234.05B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings